Skip To Main Content
Contact us
|
Help
Home
About
ADR
ADR Archives
Resources
Contact
Flash e-reader
Choose a chapter:
Introduction
Kidney
Pancreas
Liver
Intestine
Heart
Lung
Deceased Organ Donation
Allocation Policies
Appendix
Table Selection
Choose an organ:
All Organs
Kidney
Pancreas
Kidney/Pancreas
Heart
Lung
Heart/Lung
Intestine
Liver
Choose a group:
Choose a characteristic:
Requires
Adobe Acrobat Reader
Table 8.8
Adjusted Kidney Graft Survival, Kidney-Pancreas Transplants
Survival at 3 Months, 1 Year, 5 Years, and 10 Years
3 Months
1 Year
5 Years
10 Years
(Tx 2007 - 2008)
(Tx 2007 - 2008)
(Tx 2003 - 2008)
(Tx 1998 - 2008)
N
%
Std. Err.
N
%
Std. Err.
N
%
Std. Err.
N
%
Std. Err.
Total
All
1,676
95.8%
0.5%
1,676
93.0%
0.6%
5,230
79.6%
0.7%
9,824
60.7%
0.7%
Transplant Center State
Alabama
23
+
+
23
+
+
93
84.6%
4.7%
172
62.3%
5.7%
Arkansas
3
+
+
3
+
+
15
93.7%
5.9%
41
58.8%
11.6%
Arizona
76
97.4%
1.8%
76
92.2%
3.1%
150
81.2%
4.5%
217
63.2%
5.5%
California
176
95.5%
1.6%
176
91.5%
2.1%
633
81.6%
1.8%
1,183
63.5%
2.1%
Colorado
34
97.1%
2.8%
34
97.1%
2.8%
77
90.2%
4.4%
148
64.5%
6.0%
Connecticut
2
49.0%
25.4%
2
49.0%
25.4%
9
60.6%
17.0%
24
56.8%
10.9%
District of Columbia
13
92.3%
7.1%
13
92.3%
7.1%
49
76.9%
6.4%
112
55.0%
6.6%
Florida
133
96.2%
1.7%
133
94.0%
2.1%
423
80.8%
2.3%
681
61.9%
2.8%
Georgia
62
98.4%
1.6%
62
98.4%
1.6%
162
82.5%
3.9%
297
69.8%
3.5%
Hawaii
5
+
+
5
+
+
12
83.8%
10.1%
19
65.4%
12.5%
Iowa
13
100.0%
0.0%
13
92.4%
7.1%
46
91.1%
4.2%
114
74.3%
5.3%
Illinois
75
100.0%
0.0%
75
98.7%
1.3%
325
76.4%
2.7%
666
51.5%
2.8%
Indiana
56
96.4%
2.5%
56
96.4%
2.5%
167
80.4%
3.8%
203
72.9%
5.3%
Kansas
22
95.4%
4.4%
22
90.8%
6.1%
41
82.0%
6.1%
105
68.2%
5.8%
Kentucky
23
91.4%
5.7%
23
87.0%
6.8%
70
72.8%
6.1%
156
51.6%
5.8%
Louisiana
49
93.9%
3.4%
49
89.9%
4.2%
149
74.8%
4.1%
256
50.4%
5.2%
Massachusetts
6
82.9%
14.2%
6
82.9%
14.2%
23
90.2%
6.5%
46
75.9%
7.2%
Maryland
43
93.0%
3.9%
43
93.0%
3.9%
130
72.7%
6.0%
230
41.6%
5.0%
Maine
2
+
+
2
+
+
12
82.7%
10.6%
14
85.4%
9.2%
Michigan
34
91.2%
4.8%
34
85.4%
6.0%
116
85.3%
3.7%
173
65.2%
6.0%
Minnesota
39
92.2%
4.3%
39
92.2%
4.3%
125
64.3%
5.2%
340
53.2%
3.2%
Missouri
26
96.2%
3.7%
26
96.2%
3.7%
76
71.5%
7.3%
118
49.3%
7.2%
North Carolina
88
97.7%
1.6%
88
96.6%
1.9%
215
82.6%
3.1%
363
67.0%
3.7%
North Dakota
5
79.5%
16.3%
5
79.5%
16.3%
17
86.7%
8.5%
20
83.7%
8.4%
Nebraska
22
100.0%
0.0%
22
95.5%
4.3%
53
78.4%
6.2%
111
82.3%
4.0%
New Hampshire
8
100.0%
0.0%
8
87.5%
11.0%
13
91.9%
7.5%
13
92.0%
7.4%
New Jersey
45
91.2%
4.2%
45
89.0%
4.6%
113
80.3%
4.7%
188
64.0%
5.1%
Nevada
0
-
-
0
-
-
1
+
+
9
58.2%
14.8%
New York
28
96.4%
3.4%
28
92.9%
4.8%
106
77.8%
4.5%
238
61.6%
3.9%
Ohio
119
96.6%
1.6%
119
89.9%
2.8%
345
75.9%
2.9%
647
57.2%
2.8%
Oklahoma
7
85.8%
12.3%
7
85.8%
12.3%
32
69.9%
9.0%
55
57.8%
8.4%
Oregon
17
100.0%
0.0%
17
94.0%
5.6%
52
80.9%
6.7%
88
75.0%
5.6%
Pennsylvania
48
95.8%
2.9%
48
95.8%
2.9%
253
76.1%
3.1%
610
56.0%
2.7%
Puerto Rico
12
91.9%
7.5%
12
91.9%
7.5%
12
91.8%
7.5%
12
91.8%
7.6%
Rhode Island
1
+
+
1
+
+
6
55.1%
21.0%
6
55.2%
21.0%
South Carolina
27
96.4%
3.5%
27
96.4%
3.5%
68
82.4%
6.0%
147
56.6%
5.4%
South Dakota
0
-
-
0
-
-
2
+
+
2
+
+
Tennessee
38
89.5%
4.9%
38
84.2%
5.8%
118
75.8%
4.9%
253
53.6%
4.3%
Texas
110
96.4%
1.8%
110
91.9%
2.6%
299
78.7%
2.9%
540
64.3%
2.9%
Utah
20
85.2%
7.5%
20
85.2%
7.5%
66
85.8%
4.9%
108
73.7%
4.9%
Virginia
26
100.0%
0.0%
26
88.4%
6.2%
81
81.4%
5.0%
164
61.0%
5.0%
Vermont
12
+
+
12
+
+
23
84.3%
10.6%
23
84.4%
10.5%
Washington
39
97.4%
2.5%
39
97.4%
2.5%
127
89.5%
3.1%
247
65.6%
4.4%
Wisconsin
89
96.6%
1.9%
89
94.4%
2.4%
325
82.7%
2.5%
665
65.4%
2.7%
Source: OPTN/SRTR Data as of October 1, 2010.
(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.
Cohorts are transplants performed during the years listed at the top of the table.
Graft survival follows individual transplants until graft failure.
Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.
Center volume = Center's yearly transplants performed during the base period, based on kidney-pancreas and kidney transplants.
Multi-organ transplants are excluded.
Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.